drugset / Trial / NCT00082485

Baclofen for the Treatment of Cocaine Dependence - 1

NCT00082485

Phase 2 Completed 160 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.

Timeline

Start
2004-06
Primary completion
2006-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baclofen Small molecule 60 mg

Indications